Ulcerative Colitis Newswire (Page 2)

Ulcerative Colitis Newswire (Page 2)

Comprehensive Real-Time News Feed for Ulcerative Colitis. (Page 2)

Results 21 - 40 of 3,243 in Ulcerative Colitis

  1. Dozens Rally at GOP Congressman's Office Over HealthcareRead the original story w/Photo

    Tuesday Feb 21 | WNYC-AM New York

    ... benefited from Obamacare. Sarah Zorn said the ACA has covered medical treatments for her husband's ulcerative colitis, which cost $28,000 a month. "He is in an entirely remissive state, he was able to start up his own business, which has been really ...

    Comment?

  2. TSRI-Invented Compound Ozanimod Shows Positive Results in Late-Stage...Read the original story

    Tuesday Feb 21 | Newswise

    ... full study results, as well as the results from the Phase 3 study evaluating ozanimod in patients with ulcerative colitis." Scientists involved in the trial plan to present the full Phase 3 trial results at an upcoming international scientific ...

    Comment?

  3. Set To Explode: Ritter PharmaceuticalsRead the original story w/Photo

    Tuesday Feb 21 | Seeking Alpha

    ... numerous major digestive diseases. For example, this technology could be used to combat Crohn's disease, ulcerative colitis, and irritable bowel syndrome. Andrew Ritter is the Co-Founder and President of Ritter pharmaceuticals. He started the ...

    Comment?

  4. Assembly Biosciences Announces the Closing and Early Termination of...Read the original story w/Photo

    Tuesday Feb 21 | GlobeNewswire

    ... Assembly's microbiome gastrointestinal development programs, including ABI-M201 and ABI-M301, targeting ulcerative colitis and Crohn's disease, as well as two additional compounds targeting Irritable Bowel Syndromes. About Assembly Biosciences ...

    Comment?

  5. Now Available Global Smart Pill Technologies Market Forecast And Growth 2015-2025Read the original story w/Photo

    Monday Feb 20 | PR-inside.com

    ... people suffer from IBD in the United States. Prevalence of Crohn's disease is 201 per 100,000 adults and Ulcerative colitis is 238 per 100,000 adults. Also the changing lifestyle related syndromes and disorders will further boost this market. ...

    Comment?

  6. How Living With IBD Helped Me Discover My SuperpowersRead the original story w/Photo

    Monday Feb 20 | Switched

    ... at IBDunmasked.com and together we can unmask the truth behind this incessant villain. Megan has ulcerative colitis (UC) and is one of the co-founders of The Great Bowel Movement (GBM), which aims to empower those with IBD "to embrace their disease, ...

    Comment?

  7. Crohn's Disease Research 2017: How Gut Bacteria Imbalance Leads To InflammationRead the original story w/Photo

    Monday Feb 20 | Medical Daily

    More than one million Americans suffer from Inflammator Bowel Disease, according to the Centers for Disease Control and Prevention . The most common types of IBD are Crohn's disease and ulcerative colitis.

    Comment?

  8. Alex Claudio has the 'street cred' in battle among lefties for spot in Rangers bullpenRead the original story w/Photo

    Sunday Feb 19 | Dallas Morning News

    ... Diekman will miss at least the first half of the season while recovering from three surgeries related to ulcerative colitis. Claudio was the second-most used lefty in 2016 and was as reliable a reliever as the Rangers had in the final stages of the ...

    Comment?

  9. Dozens rally to keep Affordable Care ActRead the original story w/Photo

    Saturday Feb 18 | KWQC-TV Davenport

    ... worried about what the law could look like in the future. Olivia Dorathy, a mother of one was born with Ulcerative Colitis, an autoimmune disease that could have kept her from having a child. Because of the medication ACA covers, she was able to ...

    Comment?

  10. Federal Circuit Finds 'Consisting Of' Requires Reversing Infringement Of Shire Lialda PatentRead the original story w/Photo

    Saturday Feb 18 | JD Supra

    ... is the only Orange Book-listed patent for Lialda, which is approved for treating Crohn's disease and ulcerative colitis. The patent relates to a pH-independent controlled release formulation of mesalazine (also known as 5-amino-salicylic acid or ...

    Comment?

  11. Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.Read the original story w/Photo

    Saturday Feb 18 | Fox News

    ... several key clinical setbacks. In 2016, Gilead haltedphase 2/3 clinical studies ofGS-5745 in treating ulcerative colitis and decided against moving forward with a planned study of the experimental drug in treating Crohn's disease. It threw in the ...

    Comment?

  12. Why people with invisible illness shouldn't fear asking for a seat on public transportRead the original story

    Friday Feb 17 | Metro

    ... surgery after having had my large intestine removed due to it almost perforating after suffering with ulcerative colitis, a form of inflammatory bowel disease. I'd had my small intestine stitched to my rectum just months ago, and that day, I'd ...

    Comment?

  13. Getting a Colonoscopy - Colon Cancer Awareness and PreventionRead the original story w/Photo

    Friday Feb 17 | Biscayne Bay Tribune

    ... cancer. Your doctor also may take tissue samples to test for inflammatory bowel diseases such as ulcerative colitis. Bleeding in the colon can be treated by special medications, laser, heater probe or electrical probe passed through the colonoscope. ...

    Comment?

  14. Low vitamin D levels linked to relapse of ulcerative colitisRead the original story w/Photo

    Friday Feb 17 | UPI

    Researchers at Beth Israel Deaconess Medical Center in Boston have found that lower levels of vitamin D increase the risk of relapse of ulcerative colitis. Ulcerative colitis, or UC, is an inflammatory bowel disease that causes long-lasting inflammation and ulcers in the colon.

    Comment?

  15. Celltrion Healthcare Releases Positive Results From Pivotal Study In Crohn??'s DiseaseRead the original story

    Thursday Feb 16 | BioSpace

    ... and safety of CT-P13 in 74 paediatric patients with CD (naA ve patients: 26, switch patients: 25) or ulcerative colitis (UC) (naA ve patients: 16, switch patients: 7). The data show that CT-P13 is effective in both treatment-naA ve and switch ...

    Comment?

  16. Celltrion Healthcare Releases Positive Results from Pivotal Study in Crohna s DiseaseRead the original story w/Photo

    Friday Feb 17 | Business Wire

    ... and safety of CT-P13 in 74 paediatric patients with CD (naA ve patients: 26, switch patients: 25) or ulcerative colitis (UC) (naA ve patients: 16, switch patients: 7). The data show that CT-P13 is effective in both treatment-naA ve and switch ...

    Comment?

  17. Research: Many ulcerative colitis patients taking conventional...Read the original story w/Photo

    Friday Feb 17 | Medical News

    Three-quarters of those who describe their disease as moderate to severe say their disease is 'poorly controlled', with a third having had five or more flares over the past year New research shows that nearly three-quarters of patients with moderate to severe ulcerative colitis taking conventional treatments describe their disease as 'poorly controlled' , with half saying they are somewhat or completely dissatisfied with their current medication; only 1% were completely satisfied with their current treatment. Ulcerative colitis is a chronic disease, causing inflammation and ulceration of the inner lining of the rectum and colon , and is one of the two most common forms of inflammatory bowel disease I the other is Crohn's disease.

    Comment?

  18. IQ4I Research & Consultancy Published a New Report on...Read the original story

    Friday Feb 17 | PR.com

    ... related conditions (for e.g. childbirth, menopause), inflammatory bowel diseases (Crohn's disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson's disease etc), oncology (colorectal and prostate cancer) and others ...

    Comment?

  19. Celgene Announces Positive Results From Phase III Sunbeam Trial Of...Read the original story

    Thursday Feb 16 | BioSpace

    ... profile was consistent with results from previously reported phase II RMS (RADIANCE) and phase II ulcerative colitis (TOUCHSTONE) trials. "The safety and efficacy results from SUNBEAM are consistent with the long-term results from the phase II trial ...

    Comment?

  20. Janssen Biotech Release: New Data Shows STELARA (ustekinumab)...Read the original story

    Thursday Feb 16 | BioSpace

    ... with Crohn's disease, "said More than five million people worldwide are living with Crohn's disease and ulcerative colitis collectively known as inflammatory bowel disease (IBD).2 Specifically in the U.S., Crohn's disease affects as many as 780,000 ...

    Comment?